Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Amrutanjan Health Care LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:590006NSE Symbol: AMRUTANJANP/E(TTM):49.16
ISIN Demat:INE098F01031Div & Yield %:0.62EPS(TTM):15.22
Book Value(Rs):90.625131Market Cap ( Cr.):2162.95Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 379.64405.84332.84261.48253.23221.53
Excise Duty0.000.000.000.000.001.54
Net Sales379.64405.84332.84261.48253.23219.99
Other Income 14.5415.3811.328.327.137.89
Stock Adjustments 1.735.50-5.016.973.30-0.80
Total Income395.91426.72339.15276.77263.66227.08
EXPENDITURE :      
Raw Materials 183.71185.96135.18124.05122.1694.01
Power & Fuel Cost3.062.661.762.021.871.70
Employee Cost 48.8148.2341.7039.3633.3633.85
Other Manufacturing Expenses 10.388.376.666.785.726.42
Selling and Administration Expenses 88.5784.6864.7261.4559.9653.14
Miscellaneous Expenses 2.291.872.973.962.531.88
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure336.83331.77252.99237.62225.60191.00
Operating Profit59.0894.9586.1639.1538.0436.10
Interest 0.220.580.590.340.200.31
Gross Profit58.8694.3785.5738.8137.8435.79
Depreciation5.213.803.674.363.162.91
Profit Before Tax53.6590.5781.9034.4534.6832.88
Tax14.0123.3919.739.4310.2313.20
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-0.200.000.98-0.06-0.06-0.29
Reported Net Profit39.8367.1961.1925.0824.5119.97
Extraordinary Items 0.020.010.070.000.001.16
Adjusted Net Profit39.8167.1861.1225.0824.5118.81
Adjst. below Net Profit 0.000.000.00-0.63-0.51-1.38
P & L Balance brought forward214.72161.62105.1391.4474.3662.05
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 14.6714.084.7110.766.936.28
P & L Balance carried down239.89214.72161.62105.1391.4474.36
Dividend5.855.854.686.143.223.22
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %460.00460.00420.00210.00215.00152.50
Earnings Per Share-Unit Curr13.6322.9920.938.588.3913.67
Earnings Per Share(Adj)-Unit Curr13.6322.9920.938.588.396.84
Book Value-Unit Curr99.4790.7073.7554.5449.8688.03